Skip to content
MedCompare

Lapatinib

Also known as Tykerb (us), Lapanib (india)

Cancer & Oncology
Save $1,098/mo
14× cheaper

Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications.

United States
$1,184
per month
India
$86
per month
You save
$1,098
93% cheaper in India
328 US scripts/yr$360.1K potential annual savings$388.3K US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC29H26ClFN4O4S

SMILES: CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl

Compare the price
US price$1,184per month
India price$86per month
You save$1,09893% less

Based on 30 units per month. US $39.46 vs India $2.87 per unit.

Total over 1 periodSave $1,098$1,184 → $86
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$6,587
Estimated travel cost
− $2,300
Net savings after travel
$4,287

Even after travel, you could come out ahead by about $4,287.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Lapatinib is filled about 328 times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$388.3K
If sourced from India
$28.2K
Potential annual savings
$360.1K
−93%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.